Post-marketing safety experience of vedolizumab in older patients with inflammatory bowel disease (13th Congress of the European Crohn's and Colitis Organisation (ECCO 2018), 2018)

(untitled) - Travis, S; Ungaro, R; Blake, A; Bhayat, F; Card, T